Sign in
Explore the registryTrack Rp-6306's trials

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

RP-6306OngoingRecruitingPhase 2Open NCT05601440 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…